21170 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
Attenuated serovar paratyphi A and uses thereof
#602formulation
#603Medium and method of deriving and using a mutated bacteria strain
#604VACCINES AGAINST CLOSTRIDIUM DIFFICILE AND METHODS OF USE
#605Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
#606Oral vaccine
#607Antibody to cytolethal distending toxin of
#608Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
#609Vaccine strains of
#610SALMONELLA MARKER VACCINE
#611COMPOSITIONS COMPRISING PRFA* MUTANT LISTERIA AND MEHTODS OF USE THEREOF
#612Recombinant bacterium capable of eliciting an immune response against
#613based delivery system and methods of use
#614Helicobacter system and uses thereof
#615Broad spectrum vaccine against non-typhoidal
#616vectored vaccines against and methods of use
#617Recombinant bacterium capable of eliciting a protective immune response against
#618vaccine
#619Engineered Listeria and methods of use thereof
#620METHODS OF ENHANCING THE IMMUNOGENICITY OF MYCOBACTERIA AND COMPOSITIONS FOR THE TREATMENT OF CANCER, TUBERCULOSIS, AND FIBROSING LUNG DISEASES
#621Methods and Compositions for Stabilization of a Virus Vaccine
#622Methods, compositions and vaccines relating to antibodies
#623IDENTIFICATION OF GENES
#624attenuated for entry into non-phagocytic cells, vaccines comprising the and methods of use thereof
#625BACTERIAL VACCINE
#626Immunogenic formulation
#627Tissue targeted antigenic activation of the immune response to treat cancers
#628Live attenuated aldolase-negative bacterial vaccine
#629Immunization compositions and methods
#630Attenuated bacteria useful in vaccines
#631Attenuated strains
#632Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof
#633Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in the L protein coding region
#634vaccine
#635vaccines and diagnostic tests
#636Compositions and methods of enhancing immune responses to flagellated bacterium
#637Cattle vaccines
#638Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of Cancer
#639Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumors
#640Vaccine comprising recombinant CLPP protein of
#641Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
#642Use of bacterium for manufacture of a vaccine
#643Recombinant BCG tuberculosis vaccine designed to elicit immune responses to mycobacterium tuberculosis in all physiological stages of infection and disease
#644Mutated strain and use thereof in a vaccine
#645METHOD AND VACCINE FOR OPTIMIZING THE SPECIFIC IMMUNE RESPONSES
#646GAS57 mutant antigens and GAS57 antibodies
#647MYCOBACTERIAL GENES DOWN-REGULATED DURING LATENCY
#648VACCINE COMPOSITIONS AND USES THEREOF
#649Live attenuated vaccines
#650Engineered pertactin variants for vaccine use
#651Attenuated vaccine against fish pathogen sp
#652Formulation for room temperature stabilization of a live attenuated bacterial vaccine
#653IMMUNOGEN AGAINST CAMPYLOBACTER INFECTION
#654LIVE ATTENUATED SALMONELLA VACCINE
#655Live genetically attenuated malaria vaccine
#656Recombinant bacterium capable of eliciting an immune response against enteric pathogens
#657Methods of eliciting or boosting a cellular immune response
#658Compositions and methods of enhancing immune responses
#659Vaccines and Immunomodulatory Therapies for Tularemia
#660Human specific strains
#661Recombinant attenuated clostridium organisms and vaccine
#662Use of for prevention and treatment of allergic airway disorders
#663Attenuated malaria blood-stage vaccine
#664LIVE ATTENUATED SALMONELLA FOR USE AS VACCINE
#665Anti-bacterial Vaccine Compositions
#666VIRULENCE GENES, PROTEINS, AND THEIR USE
#667Immunogenic compositions against tuberculosis
#668Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expression
#669Live Attenuated Vaccine Strain for Prevention of Tularemia
#670Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
#671Mycobacterial mutants affecting host apoptosis
#672ATTENUATED LISTERIA SPP. AND METHODS FOR USING THE SAME
#673Clostridial toxin NetB
#674Interferon-β production modulating strains and methods for using same
#675Modified live vaccine of , methods of producing modified live vaccines, combination vaccines and methods of treatment
#676Vaccine for protection against disease
#677Mutant viruses and uses thereof
#678Method of preventing early infections
#679Allelic exchange mutagenesis in Map
#680Attenuated uracil auxotroph of an apicomplexan and use thereof
#681LIVE ATTENUATED SALMONELLA VACCINE
#682Attenuated FNR deficient enterobacteria
#683Modified live (JMSO strain) vaccine
#684Mutant botulinum neurotoxin serotype A polypeptide and uses thereof
#685Attenuated ehrlichiosis vaccine
#686Recombinant BCG strains with enhanced ability to escape the endosome
#687Methods and compositions using for enhancing immunogenicity by prime boost
#688Attenuated francisella and methods of use
#689based delivery system and methods of use
#690Modified live vaccine for aquatic animals
#691vaccines and uses thereof
#692Purified plasmodium and vaccine compositions
#693Use of coccidian
#694Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
#695Recombinant attenuated organisms and vaccine
#696mutants and methods
#697Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates
#698DNA promoters and anthrax vaccines
#699METHODS OF REDUCING PORCINE CIRCOVIRUS-ASSOCIATED DISEASE OUTBREAKS
#700HYBRID OPERON FOR EXPRESSION OF COLONIZATION FACTOR (CF) ANTIGENS OF ENTEROTOXIGENIC ESCHERICHIA COLI
#701DNA vaccines against tumor growth and methods of use thereof
#702LIVE BACTERIAL VACCINES RESISTANT TO CARBON DIOXIDE (CO2), ACIDIC PH AND/OR OSMOLARITY FOR VIRAL INFECTION PROPHYLAXIS OR TREATMENT
#703Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
#704KLEBSIELLA PNEUMONIAE ATTENUATED VIRULENCE MUTANT AND METHOD OF PRODUCTION
#705Tuberculosis vaccine
#706hyperexpressing recombinant cholera toxin B subunit showing dual immunogenicity
#707Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
#708Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety
#709Systems, methods and microrganisms for antibody production with type III secretion system
#710Recombinant intracellular pathogen immunogenic compositions and methods of use
#711mutants and methods of use thereof
#712INFLUENZA VACCINE
#713Live Bacteria product
#714Recombinant BCG strains with enhanced ability to escape the endosome
#715FRANCISELLA STRAIN FOR LIVE VACCINE
#716Inactivated FCV vaccines
#717Live attenuated catfish vaccine and method of making
#718Live vaccine strains of
#719LIVE, ATTENUATED PNEUMOCOCCAL VACCINE
#720Coccidiosis vaccines
#721Live attenuated aldolase-negative bacterial vaccine
#722Pro-Apoptotic Bacteria and Compositions for Delivery and Expression of Antigens
#723Methods for stimulating an immune response using bacterial antigen delivery system
#724Antimicrobial therapy for bacterial infections
#725NOVEL PRIME-BOOST COMBINATIONS OF ATTENUATED MYCOBACTERIUM
#726NON-TOXIC MUTANTS OF PATHOGENIC GRAM-NEGATIVE BACTERIA
#727Streptococcal Genes
#728disulfide bond formation proteins and uses thereof
#729Vaccines for mycoplasma bovis and methods of use
#730Live attenuated bacterial vaccine
#731MEANS AND METHODS FOR MANIPULATING SEQUENTIAL PHAGOLYSOMALCYTOSOLIC TRANSLOCATION OF MYCOBACTERIA, AND USES THEREOF
#732Live attenuated strains as a single dose vaccine against whooping cough
#733Vaccines for Mycoplasma bovis and methods of use
#734system and uses thereof
#735Attenuated yiaO mutants of bacteria
#736ATTENUATED VACCINE FOR TULAREMIA
#737Immunogenic compositions for activating γδ T cells
#738mutant with enhanced homologous recombination and uses thereof
#739strains of reduced pathogenicity, method for their preparation and uses thereof
#740Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
#741Inactivated FCV vaccines
#742Live bacteria product
#743Streptococcus Iniae Phosphoglucomutase is a Virulence Factor and Target for Vaccine Development
#744Microbial vaccine and vaccine vector
#745Adhesin-enterotoxin chimera based immunongenic composition against enterotoxigenic
#746Recombinant BCG tuberculosis vaccine designed to elicit immune responses to in all physiological stages of infection and disease
#747vaccine and methods of use thereof
#748Generation of new BCG vaccine strains protecting against the establishment of latent infection and reactivation from the latent or persistent state
#749avirulent adjuvanted live vaccine
#750Mesothelin Vaccines and Model Systems and Control of Tumors
#751Identification of residues critical for the function of the vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis
#752Mutant strain and uses thereof
#753Hydrogenase deficient bacterial strains
#754Live organism product
#755Attenuated strains
#756LIVE ATTENUATED MYCOPLASMA STRAINS
#757protein, nucleic acid sequence and uses thereof
#758Combination vaccine for poultry
#759Rotavirus Vaccine Inducing Heterotypic Cross Protection
#760Bacterial delivery of biologically active polypeptides
#761Mycobacteria with Mannose Cap-Deficient Lipoarabinomannan
#762MINICELLS AS VACCINES
#763Genetically modified parasites expressing protective tick antigens and uses thereof
#764Vaccines for diseases of fish
#765Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemorrhagic in cattle
#766Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
#767Attenuated microorganisms for the treatment of infection
#768Polyvalent attenuated live vaccine for preventing and curing vibriosis of cultivated fish
#769Combinations of gene deletions for live attenuated vaccine strains
#770Vaccine for veterinary and human medicine prophylaxis and therapy
#771USE OF AN AVIRULENT BORDETELLA MUTANT AS A LIVE VACCINE VECTOR
#772GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by
#773Vaccination against multiple serotypes of pasteurella multocida
#774VACCINATION OF HORSES AGAINST LAWSONIA INTRACELLULARIS
#775Virulence genes, proteins, and their use
#776Vaccine Composition
#777Attenuated serovar paratyphi a and uses thereof
#778Vaccines for Mycoplasma bovis and methods of use
#779vaccine
#780Avian vaccine for protection against colibacillosis
#781Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
#782Live, oral vaccine for protection against serotype 1
#783Identification of genes
#784Live Attenuated Salmonella For Use as Vaccine
#785Antibiotic resistance free vaccines and methods for constructing and using same
#786Attenuated uracil auxotroph of an apicomplexan and use thereof
#787LIVE BACTERIAL VACCINES FOR VIRAL INFECTION PROPHYLAXIS OR TREATMENT
#788PROTEINASE K RESISTANT SURFACE PROTEIN OF NEISSERIA MENINGITIDIS
#789Proteinase K resistant surface protein of
#790Proteinase K resistant surface protein of
#791Modulation of replicative fitness by deoptimization of synonymous codons
#792of european origin and vaccines, diagnostic agents and methods of use thereof
#793strains VCUSM1 and VCUSM4, method of producing same, and vaccine derivatives thereof
#794Brucella melitensis mutants and methods
#795PROTEINASE K RESISTANT SURFACE PROTEIN OF NEISSERIA MENINGITIDIS
#796Proteinase K resistant surface protein of
#797PROTEINASE K RESISTANT SURFACE PROTEIN OF NEISSERIA MENINGITIDIS
#798Recombinant BCG strains with enhanced ability to escape the endosome
#799Attenuated salmonella SP12 mutants as antigen carriers
#800Salmonella vaccine
#801Vaccines for and methods of use
#802Vaccination of young animals against infections
#803Attenuated FNR Deficient Enterobacteria
#804Global regulator of morphogenesis and pathogenicity in dimorphic fungi and uses thereof
#805Live genetically attenuated malaria vaccine
#806Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
#807Recombinant attenuated organisms and vaccine
#808Live Attenuated Bacterial Vaccine
#809Live bacteria product
#810Method of Regulating Heterologous Protein Expression Controlled by Salicylic Deratives in Micro-Organisms Associated with Higher Organisms
#811Francisella Strain for Live Vaccine
#812Lactoferrin: an adjuvant for vaccines
#813Attenuated bacteria
#814Anti-bacterial vaccine compositions
#815Construction of live attenuated vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic
#816Virulence genes of M. marinum and M. tuberculosis
#817Engineered listeria and methods of use thereof
#818Engineered and methods of use thereof
#819Use of mycrobacterial vaccines in CD4 or CD8 lymphocyte-deficient mammals
#820Development of a sp. vaccine strain
#821Antibody-mediated enhancement of immune response
#822Listeria-induced immunorecruitment and activation, and methods of use thereof
#823Method for identification of novel virulence associated genes
#824Novel therapeutic target for protozoal diseases
#825Recombinant intracellular pathogen immunogenic compositions and methods for use
#826Live Attenuated Samonella Strains for Producing Monovalent or Multivalent Vaccines
#827vaccines and diagnostic tests
#828Proteinase K resistant surface protein of
#829DNA vaccines against tumor growth and methods of use therof
#830Non-toxic mutants of pathogenic gram-negative bacteria
#831Mutant vesicular stomatitis viruses and uses thereof
#832Orally-administered live bacterial vaccines for plague
#833Therapeutic target for protozoal diseases
#834Methods of preparation of live attenuated bacterial vaccine by alteration of DNA adenine methylase (Dam) activity in those bacteria
#835Vaccines for mycoplasma bovis and methods of use
#836Vibrio cholerae with improved biological safety features in freeze dried form
#837STREPTOCOCCUS EQUI COMPOSITIONS AND METHODS OF USE
#838DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof
#839Methods of eliciting or boosting a cellular immune response
#840Non-toxic mutants of pathogenic gram-negative bacteria
#841Bacterial virulence factors and uses thereof
#842Development of a live, attenuated, recombinant vaccine for Brucellosis
#843Modified Bacillus anthracis, vaccine compositions and methods of use thereof
#844Coccidial vaccine and methods of making and using same
#845Modified mycobacterium tuberculosis strains and uses thereof
#846Lawsonia vaccine and methods of use thereof
#847Live genetically attenuated malaria vaccine
#848Modified ESAT-6 molecules and improved vaccine strains of BCG
#849Cross-beta structures on microbial organisms
#850Transformed
#851Compositions and methods to modulate pathogenesis
#852Inactivated vibrio cholerae vaccine in tablet form
#853Live attenuated vaccines
#854Cells used as carriers for bacteria
#855Vibrio cholerae vaccine candidates, the methods of their constructing and medicinal preparations derived thereof
#856Regulated attenuation of live vaccines to enhance cross-protective immunogenicity
#857Identification of genes
#858Vaccine composition
#859Immunogenic compositions comprising
#860Novel post-transcriptional regulatory elements and uses thereof
#861Methods for diagnosing and treating chronic tonsillitis
#862Methods and compositions involving LcrV proteins
#863Variants of vibrio cholerae 01 biotype e1 tor with attributes of classical biotype
#864Methods and composition for oral vaccination
#865Virulence genes, proteins, and their use
#866Inactivated FCV vaccines
#867Vaccine against Gram-negative bacterial infections
#868Streptococcal C5A peptidase vaccine
#869Process for the preparation of an improved strain plasmid to develop the strain and the vaccine comprising the said strain
#870Bacterial virulence genes
#871Live genetically engineered protozoan vaccine
#872Composition comprising a protein encoded by a modified ERP gene of
#873Recombinant BCG strains with attenuated immunosuppressive properties
#874Streptococcus equi vaccine compositions and method of use
#875Vibrio cholerae strains VCUSM1 and VCUSM4, method of producing same, and vaccine derivatives thereof
#876Development of a live, attenuated, recombinant vaccine for Brucellosis
#877-based and LLO-based vaccines
#878Composition for delivering an agent to a target cell and uses thereof
#879Attenuated live Neospora vaccine
#880Helicobacter system and uses thereof
#881Live attenuated vaccine against porcine pleuropneumonia
#882Plasmid maintenance system for antigen delivery
#883Plasmid maintenance system for antigen delivery
#884Plasmid maintenance system for antigen delivery
#885Suicidal mutant vaccine
#886Minicells as vaccines
#887Methods of use of genes of pyridoxal 5'-phosphate biosynthesis in Bacillus subtilis: avirulent strains for vaccines, and methods for identification of antibacterial agents
#888DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
#889Vaccine for protection against disease
#890Listeria-based EphA2 vaccines
#891mutants and vaccines comprising same
#892Live organism product
#893Attenuated vaccine useful for immunizations against Coccidioides spp. infections
#894Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens
#895Salmonella vaccine materials and methods
#896Mutant strains of Brucella melitensis and immunogenic compositions
#897Virulence genes, proteins, and their use
#898Live genetically attenuated malaria vaccine
#899Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of BCG and
#900Renibacterium salmoninarum vaccine